T1D Strong: Father and Son Paul and Nick Peloso Discuss Growing Up with Type 1 Diabetes and the Breakthrough T1D Therapy Paul Is Developing
Biotech TV: COUR Pharma last week raised a $50M series B to progress its nanoparticle approach to reprogramming the immune system to treat type 1 diabetes
